-
Prasugrel, sold
under the
brand names Effient and Efient, is a
medication used to
prevent formation of
blood clots. It is a
platelet inhibitor and an...
-
revascularisation (restoration of
blood flow). Like the
thienopyridines prasugrel,
clopidogrel and ticlopidine,
ticagrelor blocks adenosine diphosphate...
-
adverse effects it is not much used today. Ticlopidine,
clopidogrel and
prasugrel (Efient) are all
thienopyridines that
cause irreversible inhibition of...
-
functions and
microglial neuroprotection. The
drugs clopidogrel (Plavix),
prasugrel (Efient, Effient),
ticagrelor (Brilinta), and
cangrelor (Kengreal) bind...
-
combination of
aspirin plus an ADP/P2Y
inhibitor (such as clopidogrel,
prasugrel, ticagrelor, or another) is used to
obtain greater effectiveness than...
- esomeprazole, but
pantoprazole appears to be safe. The
newer antiplatelet agent prasugrel has
minimal interaction with (es)omeprazole,
hence might be a
better antiplatelet...
-
thrombosis and strokes.
Drugs in this
class include:
clopidogrel (Plavix),
prasugrel (Effient), and
ticlopidine (Ticlid).
Tinoridine was
actually a predecessor...
-
bioactivation of the
antithrombotic prodrugs ticlopidine, clopidogrel, and
prasugrel. As
posited in a "Thioester World",
thioesters are
possible precursors...
-
Vanflyta (quizartinib)
Zelboraf (vemurafenib)
Cardiovascular Effient (
prasugrel) (co-marketed with Eli
Lilly and Company; also sold as Efient) Lixiana/Savaysa...
- D; Rosi; Debernardi; Bertho;
Mansuy (2012). "Metabolic
Activation of
Prasugrel:
Nature of the Two
Competitive Pathways Resulting in the
Opening of Its...
